Clinical, pathomorphological and immunohistochemical evaluation of tissue repair in diabetic foot ulcers

Background: It is known that wound healing is Impaired in diabetes mellitus. Possible reasons are widely being searched. However, despite all the available data, reliable markers of reparative processes in diabetes mellitus are needed to be found.

Aim: To study morphological and some immunohistochemical markers of tissue repair in patients with diabetic foot ulcers after local treatment.

Materials and methods: 70 patients with diabetic foot ulcers before and after surgical debridement were included. Histological (light microscopy) and immunohistochemical (CD68, MMP-9, TIMP-1) characteristics of tissue repair processes in soft tissues of the lower extremities in patients with diabetes mellitus were analyzed. Histological and immunohistochemical examination of soft tissues were performed in 63 patients before and after surgical debridement and 10 days after local treatment.

Results: After the surgical debridement a significant reduction in the area of wounds was registered by 23.4% (p <0.05), wound depth by 29.4% (p <0.05). Based on the results of the morphological study, the presence of mature granulation tissue in the wounds was confirmed. Immunohistochemical study of wound biopsies demonstrated a significant decrease in proteolytic activity in the wound as a decrease in MMP-9 expression (p <0.05). Statistically significant changes in the number of macrophages against the initial data were not found, as well as increased expression of TIMP-1 was observed (p> 0.05 and <0.05, respectively).

Conclusion: According to the data, there was a significant decrease in the area and depth of wounds during local treatment. The intensity of tissue repair was confirmed by the results of histological and immunohistochemical studies. However, the absence of a statistically significant change in the amount of macrophages on the background of treatment suggests that this repair link is disrupted in diabetes mellitus, which is the reason for the "chronic" wounds and requires further studies.

diabetes mellitus, chronic wounds, repair, immunohistochemical markers, histology

1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228. doi:10.1001/jama.293.2.217

2. Lipsky BA, Weigelt JA, Sun X, et al. Developing and validating a risk score for lower- extremity amputation in patients hospitalized for a diabetic foot infection. Diabetes Care. 2011;34(8):1695-1700. doi:10.2337/dc11-0331

3. Галстян Г.Р., Викулова О.К., Исаков М.А., и др. Эпидемиология синдрома диабетической стопы и ампутаций нижних конечностей в Российской Федерации по данным Федерального регистра больных сахарным диабетом (2013–2016 гг.) // Сахарный диабет. – 2018. – Т. 21. – №3. – С. 170-177. [Galstyan GR, Vikulova OK, Isakov MA, et al. Trends in the epidemiology of diabetic foot and lower limb amputations in Russian Federation according to the Federal Diabetes Register (2013–2016). Diabetes mellitus. 2018;21(3):170-177. (In Russ.)] doi: 10.14341/DM9688

4. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219–1222. doi: 10.1172/JCI32169

5. López-López N, González-Curiel I, Treviño-Santa Cruz MB, et al. Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers. Arch Dermatol Res. 2014;306(9):809–821. doi: 10.1007/s00403-014-1494-2

6. Airola K., Karonen T, Vaalamo M, et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer. 1999;80(5-6):733-743. doi: 10.1038/sj.bjc.6690417

7. Bikle DD, Oda Y, Xie Z. Vitamin D and skin cancer: a problem in gene regulation. J Steroid Biochem Mol Biol. 2005;97(1–2):83–91. doi: 10.1016/j.jsbmb.2005.06.001

8. Adler AI, Erqou S, Lima TA, Robinson AH. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus—review and meta-analysis. Diabetologia. 2010;53(5):840-849. doi: 10.1007/s00125-009-1638-7

9. Bahar-Shany K, Ravid A, Koren R. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D. J Cell Physiol. 2010;222(3):729–737. doi: 10.1002/jcp.22004

10. Bullard KM, Lund L, Mudgett JS, et al. Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg. 1999;230(2):260–265. doi: 10.1097/00000658-199908000-00017

11. Зайцева Е.Л., Доронина Л.П., Молчков Р.В., и др. Морфологическая и иммуногистохимическая характеристика интенсивности репаративных процессов в мягких тканях нижних конечностей у лиц с нейропатической и нейроишемической формами синдрома диабетической стопы // Сахарный диабет. – 2015. – Т. 18. – №4. – C. 72-78. [Zaitseva EL, Doronina LP, Molchkov RV, et al. The morphological characteristic of tissue repair in patients with neuropathic and neuroischemic forms of diabetic foot syndrome. Diabetes mellitus. 2015;18(4):72-78. (In Russ.)] doi: 10.14341/DM7587

12. Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. / Под ред. Дедова И.И., Шестаковой М.В., Майорова А.Ю. 8-й выпуск // Сахарный диабет. – 2017. – Т. 20. – №1S. – C. 1-121. [Dedov II, Shestakova MV, Mayorov AY, et al. Dedov II, Shestakova MV, Mayorov AY, editors. Standards of specialized diabetes care. 8th ed. Diabetes mellitus. 2017;20(1S):1-121. (In Russ.)] doi: 10.14341/DM20171S8

13. Li G, Zou X, Zhu Y, et al. Expression and Influence of Matrix Metalloproteinase–9/Tissue Inhibitor of Metalloproteinase–1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers. Int J Low Extrem Wounds. 2017;16(1):6–13. doi: 10.1177/1534734617696728

14. Liu Y, Min D, Bolton T, et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 2009;32(1):117-119. doi:10.2337/dc08-0763

15. Ferguson MW, Herrick SE, Spencer MJ, et al. The histology of diabetic foot ulcers. Diabet Med. 1996;13(Suppl 1):S30-33. doi: 10.1002/dme.1996.13.s1.30